Orofacial pain in 1916 patients with early or moderate Parkinson disease

O’Neill, Francis; Kobylecki, Christopher; Carrasco, Roberto; Hu, Michèle; Grosset, Donald; Silverdale, Monty

doi:10.1097/pr9.0000000000000923

Cited by 10 publications

(33 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In total, nine studies reported unspecified pain in the orofacial area (Adewusi et al, 2018 ; Agrawal et al, 2021 ; Behari et al, 2020 ; Bonenfant et al, 2016 ; de Mattos et al, 2019 ; García et al, 2021 ; Martinez‐Martin et al, 2017 ; O'Neill et al, 2021 ; Rodríguez‐Violante et al, 2017 ), of which two included a control group (Adewusi et al, 2018 ; Martinez‐Martin et al, 2017 ). The within‐group results showed prevalences that varied between 12 and 74%.…”

Section: Resultsmentioning

confidence: 99%

“…Of the 11 studies that examined TMD pain (Bakke et al, 2011 ; Behari et al, 2020 ; Bonenfant et al, 2016 ; de Mattos et al, 2019 ; Martinez‐Martin et al, 2017 ; Mylius et al, 2021 ; O'Neill et al, 2021 ; Persson et al, 1992 ; Verhoeff et al, 2018 ; Verhoeff et al, 2022 ; Wooten Watts et al, 1999 ), five studies included a control group (Bakke et al, 2011 ; Martinez‐Martin et al, 2017 ; Persson et al, 1992 ; Verhoeff et al, 2018 ; Wooten Watts et al, 1999 ). The within‐group results showed prevalences that varied between 0 and 33%.…”

Section: Resultsmentioning

confidence: 99%

“…Of the 10 studies that examined BMD symptoms in PD patients (Behari et al, 2020 ; Bonenfant et al, 2016 ; Clifford & Finnerty, 1995 ; Clifford et al, 1998 ; de Mattos et al, 2019 ; Gopalakrishnan et al, 2021 ; Martinez‐Martin et al, 2017 ; O'Neill et al, 2021 ; van Stiphout et al, 2018 ; Verhoeff et al, 2022 ), two studies included a control group (Martinez‐Martin et al, 2017 ; van Stiphout et al, 2018 ). The within‐group results showed prevalences that varied between 1.7 and 30%.…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review

Verhoeff

Koutris

Tambach

et al. 2022

European Journal of Pain

View full text Add to dashboard Cite

Background Parkinson's disease (PD) is commonly known as a disorder that affects the smooth performance of body movements. In addition to the motor impairments, patients with PD often experience pain. Both motor impairments and pain can occur throughout the body, hence including the orofacial region. However, currently, there is a lack of knowledge on the orofacial manifestations. Since orofacial pain and dysfunction can, amongst others, reduce the quality of life of patients with PD, it is important to explore the prevalence of these symptoms in the PD population. Objective To provide a broad overview of the relevant literature on orofacial pain and dysfunction in patients with PD. Furthermore, we aim to generate hypotheses for future research on this topic. Databases and data treatment A literature search (in PubMed, http://embase.com, Web of Science [Core collection], and Cochrane Library) was performed on 20 January 2022, in collaboration with a medical librarian. In total, 7180 articles were found, of which 50 were finally included in this scoping review. Results In the included studies, pain (e.g. orofacial pain (N = 2) and temporomandibular disorder pain (N = 2)), orofacial motor dysfunction (e.g. limited jaw movements (N = 10), reduced maximum muscle output (N = 3), chewing difficulties (N = 9), unspecified TMD (N = 3), sensory disturbances (N = 1)), and bruxism (N = 3) were observed more often in patients with PD than in healthy controls. Conclusion Patients with PD experience more pain in the orofacial area and more dysfunction of the masticatory system than their healthy peers. Significance This scoping review can increase health care providers' awareness of the problems that can be encountered in the orofacial area of PD patients, especially pain syndromes also occur in the orofacial region and not only in the extremities. Besides, dysfunction of the orofacial area is elaborated in this scoping review, which helps to understand that this limits PD patients' quality of life. Further, the outcomes of this scoping review can assist in encouraging collaboration between medicine and dentistry. Finally, this scoping review suggests new research areas, based on the gaps identified in the current literature on this topic. Ultimately, this will improve individualized strategies for reducing orofacial pain and/or dysfunction in PD patients.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review

Verhoeff

Koutris

Tambach

et al. 2022

European Journal of Pain

View full text Add to dashboard Cite

show abstract

“…This can increase the incidence of dental pathology, resulting in, for example, dental pain and, therefore, reduced quality of life. Besides, O’Neill et al (2021) reported a prevalence of orofacial pain in PD patients of 7.3%, associated with oral motor dysfunction 26 . Orofacial pain can greatly influence vital human needs like eating and chewing, which can have a negative impact on the quality of life of those who suffer from orofacial pain 27 .…”

Section: Discussionmentioning

confidence: 99%

“…Besides, O’Neill et al (2021) reported a prevalence of orofacial pain in PD patients of 7.3%, associated with oral motor dysfunction. 26 Orofacial pain can greatly influence vital human needs like eating and chewing, which can have a negative impact on the quality of life of those who suffer from orofacial pain. 27 It would be logical to suggest that when people experience and report a deteriorated oral health, they would also report a worsened OHRQoL.…”

Section: Discussionmentioning

confidence: 99%

Oral health‐related quality of life in patients with Parkinson’s disease

Verhoeff

Lobbezoo

Leeuwen

et al. 2022

J of Oral Rehabilitation

View full text Add to dashboard Cite

Parkinson's disease (PD) is a degenerative neurological condition in which dopamine levels in specific parts of the brain (e.g., striatum) are reduced. 1 Due to factors like the ageing of the population, 2 its estimated prevalence (currently 2 per 1,000 persons in The Netherlands) is expected to increase in the near future. 3 Although PD is well-known for its motor symptoms (e.g., tremor, rigidity, bradykinesia), 1 non-motor

show abstract

Exercise Improves Orofacial Pain and Modifies Neuropeptide Expression in a Rat Model of Parkinson’s Disease

2023

View full text Add to dashboard Cite

Orofacial pain in 1916 patients with early or moderate Parkinson disease

Abstract: This article reports the largest epidemiological study of orofacial pain prevalence in patients with Parkinson disease to date.

Cited by 10 publications

References 49 publications

Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review

Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review

Oral health‐related quality of life in patients with Parkinson’s disease

Exercise Improves Orofacial Pain and Modifies Neuropeptide Expression in a Rat Model of Parkinson’s Disease

Contact Info

Product

Resources

About